Home Must Reads Oregonians pay 10 times more for prescription drugs

Oregonians pay 10 times more for prescription drugs

| Print |  Email
Must Reads
Friday, July 12, 2013

Oregonians have paid 10 times more for top-selling prescription drugs due to deals between drug manufacturers to delay generics.

The 20 top prescription drugs that paid off their rivals to keep generics off the market resulted in average delays of five years that left patients paying up to 33 times as much for brand names, according to a report released Thursday from the Oregon State Public Interest Group and Community Catalyst. The drugs listed include some common prescriptions: Lipitor, Tamoxifen and Cipro.

The report comes in the midst of heightened efforts nationwide to rein in health care costs, including from prescription drugs. The Supreme Court ruled last month that the Federal Trade Commission can sue companies for paying rivals to keep generic drugs off the shelves.

Read more at OregonLive.com.

{biztweet}prescription drug{/biztweet}

 

More Articles

Fly Zone

November/December 2014
Wednesday, October 22, 2014
BY JOE ROJAS-BURKE

The black soldier fly’s larvae are among the most ravenous and least picky eaters on earth.


Read more...

A Complex Portrait: Immigration, Jobs and the Economy

November/December 2014
Wednesday, October 22, 2014
BY JOE ROJAS-BURKE & KIM MOORE

Oregon Business reports on the visa squeeze, the skills gap and foreign-born residents who are revitalizing rural Oregon.


Read more...

Reimagining education to solve Oregon's student debt and underemployment problems

News
Thursday, November 13, 2014
carsonstudentdept-thumbBY RYAN CARSON | OP-ED CONTRIBUTOR

How do we skill up our future technology workforce in a smart way to take advantage of these high-paying jobs? The answer shouldn’t focus only on helping people get a bachelor’s degree.


Read more...

Two Sides of the Coin

Contributed Blogs
Wednesday, October 22, 2014
22 twosidesBY JASON NORRIS

Historically, when the leaves fall, so do the markets. This year, earnings, Europe, energy and Ebola have in common? Beyond alliteration, they are four factors that the investors are pointing to for this year’s seasonal volatility.


Read more...

The short list: 5 companies making a mint off kale

The Latest
Thursday, November 20, 2014
kale-thumbnailBY OB STAFF

Farmers, grocery stores and food processors cash in on kale.


Read more...

Healthcare pullback

News
Thursday, November 20, 2014
112014-boehnercare-thumbBY JASON NORRIS | OB CONTRIBUTOR

Each month for Oregon Business, we assess factors that are shaping current capital market activity—and what they mean to investors. Here we take a look at two major developments regarding possible rollbacks of the Affordable Care Act (ACA).


Read more...

Innovation: a critique

News
Wednesday, October 08, 2014
1008 innovation thumbBY LINDA BAKER | OB EDITOR

A Design Week panel discussion raises questions about how innovative we really are.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS